Following scandals at Curaleaf and CannTrust, CNBC host Jim Cramer said investors need to be “incredibly selective” about choosing pot stocks.
- CannTrust, a once respected Canadian producer, faces a “quasi-criminal” investigation after it was found growing tons of pot in unlicensed rooms. ????Jesse has all the details at WeedWeek Canada!
Financial Post - Following a warning from the FDA, Curaleaf has scrubbed CBD-related health claims from its Web site.
CNBC - Some pot stocks fell as much as 20% in July.
- “Some analysts are talking about CannTrust contagion,” Cramer said, though he said he still likes Canopy Growth and Cronos Group.
Cannabis Wire learned Canadian giant Canopy Growth has expanded its U.S. lobbying to New York, Pennsylvania and Illinois. It also lobbies the federal government.
- Aphria was a rare Canadian company to report a profitable quarter. Bloomberg visits its Jamaican MED farm.
MJBiz
